Article ; Online: Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.
2022 Volume 13, Page(s) 915837
Abstract: γδ T-cells directly recognize and kill transformed cells independently of HLA-antigen presentation, which makes them a highly promising effector cell compartment for cancer immunotherapy. Novel γδ T-cell-based immunotherapies, primarily focusing on the ... ...
Abstract | γδ T-cells directly recognize and kill transformed cells independently of HLA-antigen presentation, which makes them a highly promising effector cell compartment for cancer immunotherapy. Novel γδ T-cell-based immunotherapies, primarily focusing on the two major γδ T-cell subtypes that infiltrate tumors ( |
---|---|
MeSH term(s) | Humans ; Immunotherapy ; Intraepithelial Lymphocytes ; Neoplasms ; Receptors, Antigen, T-Cell, gamma-delta/metabolism ; T-Lymphocyte Subsets |
Chemical Substances | Receptors, Antigen, T-Cell, gamma-delta |
Language | English |
Publishing date | 2022-06-16 |
Publishing country | Switzerland |
Document type | Journal Article ; Review ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2606827-8 |
ISSN | 1664-3224 ; 1664-3224 |
ISSN (online) | 1664-3224 |
ISSN | 1664-3224 |
DOI | 10.3389/fimmu.2022.915837 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.